title: Acute myeloid leukemia with t(11;19)(q23;p13) developing in an adult T-cell leukemia patient treated with combined chemotherapy including etoposide.
authors.forename: N
authors.initials: N
authors.lastname: Kanemura
authors.forename: H
authors.initials: H
authors.lastname: Tsurumi
authors.forename: T
authors.initials: T
authors.lastname: Hara
authors.forename: T
authors.initials: T
authors.lastname: Yamada
authors.forename: M
authors.initials: M
authors.lastname: Sawada
authors.forename: T
authors.initials: T
authors.lastname: Naito
authors.forename: H
authors.initials: H
authors.lastname: Moriwaki
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols; D002880:Chromosomes, Human, Pair 11; D002888:Chromosomes, Human, Pair 19; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000209:etiology / Q000235:genetics; D014178:Translocation, Genetic
chemical_list: D005047:Etoposide